Medicine for treating idiopathic thrombocytopenic purpura

Abstract

The invention relates to a medicine for treating idiopathic thrombocytopenic purpura. The medicine is prepared from the following raw pharmaceutical materials in parts by weight: 12 parts of rubia cordifolia, 5 parts of ligusticum daucoides, 26 parts of phyllanthus urinaria, 17 parts of stringy stonecrop, 10 parts of radix Patriniae Scabrae, 18 parts of tender catchweed bedstraw herb and 7 parts of cortex dictamni. According to the medicine, the rubia cordifolia has the effects of promoting blood circulation and arresting bleeding, clearing and activating channels and collaterals and relieving cough and dispelling phlegm; the ligusticum daucoides has the effects of dispelling wind and clearing heat, descending Qi and resolving phlegm and promoting blood flow to regulate menstruation; the phyllanthus urinaria has the effects of reducing fever and causing diuresis and improving eyesight and removing stagnation of Qi; the stringy stonecrop has the effects of clearing away heat and promoting diuresis and detoxifying and promoting subsidence of swelling; the radix Patriniae Scabrae has the effects of drying dampness to stop leukorrhagia, astringing to stop bleeding and clearing away heat and toxic materials; the tender catchweed bedstraw herb has the effects of clearing away heat and toxic materials and inducing diuresis to reduce edema; the cortex dictamni has the effects of clearing heat and drying dampness, dispelling wind and arresting itching and detoxifying. The effects of purging pathogenic fire and clearing heat, promoting blood circulation and regulating Qi and nourishing Yin and tonifying kidney are achieved through jointly using the medicines. Proved by clinical trials, the medicine can be used for treating the idiopathic thrombocytopenic purpura safely and effectively.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating primary thrombocytopenic purpura. Background technique [0002] Idiopathic thrombocytopenic purpura (Idiopathicthrombocytopenicpurpura, ITP) is a syndrome related to autoimmunity and is a common bleeding disorder. It is characterized by the presence of anti-platelet antibodies in the blood circulation, causing excessive damage to platelets and causing purpura; while the megakaryocytes in the bone marrow are normal or increased, and are naive. It manifests as petechiae and ecchymosis on the skin and mucous membranes, or gingival bleeding, epistaxis, and menorrhagia. In severe cases, visceral bleeding may occur. The disease can be divided into two types clinically: the acute type is more common in children or young people, with sudden onset, chills, fever, followed by purple epilepsy in the skin and mucous membranes, a significant decrease in platelet count...

AI Technical Summary

Problems solved by technology

[0008] ③ The specific role of cellular immunity in the pathogenesis is unclear

[0028] (danazol, alkyne hydroxyandrostenoxazole) is a synthetic androgen, but its androgenic effect has been weakened

Images